Avian Mycoplasmosis in Poultry Flocks: Diagnostic Approaches and Control Strategies

Introduction

Avian mycoplasmosis is a chronic respiratory and synovial disease complex caused by infection with pathogenic species of the genus Mycoplasma, primarily Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS). These cell wall deficient bacteria are highly adapted to the avian host and are responsible for substantial economic losses in commercial poultry production worldwide. In broiler flocks, MG infection leads to increased feed conversion ratios, reduced weight gain, and enhanced susceptibility to secondary respiratory pathogens such as Escherichia coli and infectious bronchitis virus. In layer and breeder flocks, egg production declines and eggshell quality abnormalities, including shell apex defects associated with MS, reduce profitability. The disease is also prevalent in backyard and smallholder flocks, where limited diagnostic capacity and biosecurity resources allow silent circulation.

MG and MS are transmitted vertically through the egg and horizontally via respiratory aerosols, contaminated feed, water, and fomites. Once introduced, these pathogens establish chronic infections that are difficult to eradicate. Effective control relies on accurate and timely diagnosis followed by implementation of strict biosecurity, vaccination, and, where feasible, antimicrobial treatment or eradication programs. This article reviews the current state of diagnostic technologies and control strategies for avian mycoplasmosis, with emphasis on molecular methods, serological interpretation, and practical application in both commercial and backyard settings.

Pathogen Biology and Clinical Manifestations

Mycoplasma gallisepticum

MG is the primary etiological agent of chronic respiratory disease (CRD) in chickens and infectious sinusitis in turkeys. The bacterium colonizes the ciliated epithelial cells of the upper and lower respiratory tract. Its major virulence factors include the cytadhesin protein GapA, the cytadherence accessory protein CrmA, and the variable lipoprotein hemagglutinin (VlhA) family, which mediates antigenic variation and immune evasion [1, 2]. The hemagglutination activity of MG is a basis for serological testing.

Clinical signs in chickens include coughing, sneezing, nasal discharge, conjunctivitis, and rales. In turkeys, infraorbital sinus swelling is common. Morbidity is high; mortality is low unless complicated by secondary infections. In layers, egg production drops by 10 to 30%, and hatchability is reduced [3].

Mycoplasma synoviae

MS primarily causes infectious synovitis and subclinical respiratory infections. It can also induce eggshell apex abnormalities in layers without explicit clinical signs in the reproductive tract. MS strains vary in tissue tropism; some are highly arthrogenic, producing joint swelling, lameness, and breast blisters, while others remain confined to the respiratory mucosa [4]. The organism expresses a hemagglutinin protein (MshA) and surface lipoproteins subject to phase variation [5].

Both MG and MS are fastidious organisms requiring enriched media, slow growth, and are susceptible to desiccation and common disinfectants, though their intracellular persistence complicates clearance.

Diagnostic Approaches

Accurate diagnosis of avian mycoplasmosis requires a combination of clinical observation, pathology, serology, and molecular detection. Each method has inherent strengths and limitations.

Culture and Isolation

Isolation of Mycoplasma from tracheal swabs, choanal cleft swabs, air sac exudate, or synovial fluid is the historical gold standard. Samples are inoculated into Friis, Frey, or modified Hayflick media supplemented with nicotinamide adenine dinucleotide (NAD) for MS. Colonies appear as fried-egg morphology after 3 to 10 days of incubation. However, culture sensitivity is low, particularly in chronically infected flocks or after antimicrobial treatment, and requires specialized training. For these reasons, culture is rarely used as a standalone diagnostic method [6].

Serological Assays

Serological testing is widely employed for flock-level surveillance. The most common assays are the rapid serum agglutination (RSA) test, the hemagglutination inhibition (HI) test, and enzyme-linked immunosorbent assay (ELISA).

Rapid Serum Agglutination (RSA). RSA uses stained MG or MS antigen that agglutinates in the presence of specific antibodies. It is rapid, inexpensive, and suitable for field screening. However, it has moderate specificity due to cross-reactions with other Mycoplasma species and nonspecific agglutinins. Positive results should be confirmed by HI or ELISA [7].

Hemagglutination Inhibition (HI). The HI test is species specific and quantifies antibody titers. It requires standardized antigen and is more labor intensive than RSA. HI is the reference method for serotyping and for evaluating vaccine responses [8].

ELISA. Commercial ELISA kits (indirect format) are available for both MG and MS. They use whole cell or recombinant antigens and can differentiate between MG and MS. ELISA offers high throughput, objectivity, and suitability for automation. Sensitivity and specificity are generally above 90% when compared to culture and PCR. The primary limitation is the inability to distinguish between vaccinated and naturally infected birds (DIVA discrimination) unless specially designed subunit or marker vaccines are used [9].

Table 1 compares the principal serological tests.

Table 1. Comparative Summary of Serological Tests for Avian Mycoplasmosis.

Seroconversion typically occurs 1 to 3 weeks post infection. In vertically infected chicks, maternal antibodies persist for 2 to 4 weeks, complicating early detection.

Molecular Diagnostics

Polymerase chain reaction (PCR) and its quantitative variant (qPCR) have become the diagnostic gold standard for avian mycoplasmosis due to their superior sensitivity, specificity, and speed.

Conventional PCR. Targeted genes include the mgc2 gene for MG and the vlhA gene for MS. Multiplex PCR assays that simultaneously detect MG, MS, and often M. meleagridis are available [10]. Detection limits are typically 10 to 100 genome equivalents per reaction. Nested PCR increases sensitivity but carries higher contamination risk [11].

Real-Time PCR (qPCR). qPCR using TaqMan or SYBR Green chemistry allows quantification of bacterial load. The gapA gene and the intergenic spacer region (IGSR) are common targets. qPCR can detect as few as 1 to 5 copies. It reduces turnaround time to under two hours and enables high-throughput processing [12]. The use of melt curve analysis achieves differentiation between MG and MS in a single reaction.

Genotyping and Sequencing. For epidemiological studies, sequence analysis of the vlhA gene and multilocus sequence typing (MLST) differentiate strains and track transmission networks. Next generation sequencing (NGS) of whole genomes provides the highest resolution for outbreak investigations and antimicrobial resistance profiling [13].

Pooled Sample Testing. To reduce costs in surveillance, tracheal swabs from multiple birds can be pooled. PCR on pools of up to 5 swabs maintains high sensitivity, though the positive predictive value declines with very low prevalence [14].

Point-of-Care Molecular Tests. Isothermal amplification methods, such as loop mediated isothermal amplification (LAMP), have been developed for MG and MS detection. LAMP does not require thermocyclers and yields results in 30 to 60 minutes. Sensitivity is comparable to qPCR, making LAMP attractive for field deployment in backyard flocks and resource limited settings [15].

Diagnostic Decision Tree

The following Mermaid diagram outlines a diagnostic and control algorithm for a suspect mycoplasmosis outbreak in a commercial layer flock.

flowchart TD
    A["Clinical signs: respiratory, egg drop, synovitis"], > B["Collect tracheal swabs and sera"]
    B, > C["RSA flock screening (20 birds)"]
    C, > D{"RSA positive?"}
    D, >|Yes| E["Confirm with HI or ELISA (MG/MS specific)"]
    D, >|No| F["Monitor; consider qPCR if high suspicion"]
    E, > G{"qPCR on pooled swabs"}
    G, >|Positive| H["Identify species and quantify load"]
    H, > I["Differentiate vaccine vs field strain? Sequence vlhA"]
    I, > J["Implement control: biosecurity, vaccination review, or antimicrobial treatment"]
    G, >|Negative| K["Recheck flock in 2 weeks or test for other pathogens"]
    J, > L["Post-treatment monitoring: qPCR and serology at 4 weeks"]
    L, > M{"Resolved?"}
    M, >|Yes| N["Maintain biosecurity"]
    M, >|No| O["Consider depopulation for breeder flocks"]

Control Strategies

Biosecurity

Biosecurity forms the foundation of mycoplasmosis prevention. Because MG and MS are predominantly transmitted horizontally and vertically, stringent measures are necessary at multiple levels.

Farm-Level Measures. All in all out production, thorough cleaning and disinfection between cycles, and a downtime period of at least 2 weeks reduce pathogen carryover. Effective disinfectants include quaternary ammonium compounds, glutaraldehyde, and accelerated hydrogen peroxide applied after removal of organic matter [16].

Airborne Transmission. MG can travel up to several kilometers under favorable meteorological conditions. Filtration of incoming air in positive pressure ventilated houses and maintaining distances of at least 1 km between poultry sites reduce the risk [17].

Personnel and Equipment. Dedicated footwear, clothing, and equipment for each house, footbaths with virucidal disinfectants, and restricted visitor access are standard.

Rodent and Insect Control. Rodents and darkling beetles (Alphitobius diaperinus) can mechanically carry mycoplasmas and should be actively managed [18].

Vertical Transmission Control. In breeder flocks, testing and culling of positive birds or entire positive flocks (test and removal) is practiced in high health production systems. Antimicrobial egg treatment with gentamicin or tylosin is used in some regions but is not fully effective and raises resistance concerns [19].

Vaccination

Vaccination is a critical tool for reducing clinical signs and transmission, particularly in multiage commercial layer complexes where eradication is impractical.

Live Attenuated Vaccines. The most commonly used MG vaccines are the F strain, ts-11, and 6/85 strains. F strain is moderately virulent and can spread to unvaccinated birds, which may be a disadvantage in regions aiming for eradication. ts-11 is temperature sensitive, highly attenuated, and provides strong protection against challenge. 6/85 is also safe but induces lower antibody titers, complicating serological monitoring [20]. For MS, the live strain MS-H (Vaxsafe MS) is widely used; it is temperature sensitive and colonizes the respiratory tract without causing disease [21].

Bacterin Vaccines. Inactivated oil emulsion vaccines induce high antibody titers and are used primarily in layers and breeders. They do not prevent colonization but reduce egg production losses and airsacculitis. Bacterins typically require two injections [22].

DIVA Strategies. Marker vaccines and companion diagnostic tests allow differentiation of infected from vaccinated animals. For MG, a recombinant vaccine lacking the vlhA gene region combined with a serological test for antibodies against that region has been developed but is not commercially available on a large scale [23].

Antimicrobial Therapy

Antimicrobials are used for treatment of clinical outbreaks and for reduction of egg transmission in breeders. However, they do not eliminate infection and are subject to regulatory withdrawal periods.

Effective Drug Classes. Macrolides (tylosin, tilmicosin, tylvalosin) and tetracyclines (chlortetracycline, doxycycline) are most commonly used. Tylosin is administered in drinking water or via injection. Tilmicosin is effective but carries cardiotoxicity risk if misadministered in turkeys [24]. Florfenicol and enrofloxacin also show activity, but fluoroquinolone use is restricted in several countries.

Resistance. Antimicrobial resistance in MG and MS is increasingly reported. Macrolide resistance due to 23S rRNA gene mutations is documented in field isolates from Europe and Asia [25]. For this reason, culture and susceptibility testing, though slow, are recommended when treatment fails.

Withdrawal Times. Withdrawal periods vary by jurisdiction. In the United States, tylosin requires zero days withdrawal for eggs; other drugs require prolonged withdrawal. Careful adherence is mandatory to avoid violative residues.

Eradication in Breeder Flocks

Commercial broiler and primary breeder companies often pursue eradication based on repeated testing and depopulation. The strategy includes:

• Testing of all birds at the pullet stage by serology and PCR.
• Removal of positive individuals or entire positive houses.
• Repopulation with mycoplasma free stock.
• Strict biosecurity to prevent reintroduction.

Eradication success rates are high in single age sites but decline in multiage complexes and in regions with high flock density [26].

Special Considerations for Backyard Flocks

Backyard and smallholder flocks present unique challenges for mycoplasmosis management. Diagnosis is rarely performed due to cost and lack of access to veterinary laboratory services. Clinical signs such as sneezing or swollen sinuses are often mistaken for respiratory viruses. Serological testing using RSA is practical but has poor specificity in this population because of exposure to other Mycoplasma species.

Control in backyard settings relies on biosecurity recommendations: avoid mixing birds of different ages and sources; quarantine new birds for 3 to 4 weeks; clean coops regularly; and separate domestic poultry from waterfowl and wild birds. Vaccination is available only through veterinary purchase and is rarely used in small flocks. Treatment with over the counter antimicrobials is common but often ineffective due to inadequate dosing, duration, and growing resistance. Educational outreach programs that emphasize source control and hygiene are more sustainable than reliance on antimicrobials [27].

Conclusion

Avian mycoplasmosis remains a significant challenge to global poultry health and productivity. Advances in molecular diagnostics, particularly qPCR and LAMP, now enable rapid and sensitive detection of MG and MS at the flock level. Serological tests, while useful for surveillance, require careful interpretation in vaccinated populations. Control is best achieved through integrated strategies that combine robust biosecurity, strategic vaccination, prudent antimicrobial use, and, where feasible, eradication. For backyard flocks, accessible diagnostics and education are essential to reduce the silent spread of these chronic pathogens. Continued research into DIVA vaccines and point of care molecular tools will further strengthen the ability of veterinarians and producers to manage avian mycoplasmosis effectively.

References

[1] Baseman JB, Tully JG. Mycoplasma adherence: mechanisms and consequences. Infect Immun. 1997;65(9):3451-3458.

[2] Papazisi L, Frasca S, Gladd M, et al. GapA and CrmA coexpression is essential for Mycoplasma gallisepticum cytadherence and virulence. Infect Immun. 2002;70(12):6839-6845.

[3] Ley DH, Yoder HW. Mycoplasma gallisepticum infection. In: Saif YM, ed. Diseases of Poultry. 13th ed. Wiley; 2013:807-834.

[4] Landman WJ, Feberwee A. A longitudinal study of eggshell apex abnormalities in layer flocks with Mycoplasma synoviae infection. Avian Pathol. 2012;41(5):485-491.

[5] Reckling K, Lysnyansky I, Yogev D, et al. The M. synoviae MshA hemagglutinin is a phase variable surface adhesin. PLoS One. 2009;4(9):e7059.

[6] Giannopoulos A, Hadjigeorgiou M, Vougat A, et al. Comparison of culture and PCR for the detection of Mycoplasma gallisepticum and M. synoviae in broilers. Avian Dis. 2015;59(2):252-256.

[7] Feberwee A, de Vries T, Landman WJ. Serological monitoring of Mycoplasma synoviae in layer flocks: comparison of RSA, HI, and ELISA. Avian Pathol. 2008;37(6):615-619.

[8] Whithear KG. Control of avian mycoplasmoses by vaccination. Rev Sci Tech. 1996;15(4):1527-1553.

[9] Kleven SH. Chicken and turkey mycoplasma infections. In: Barnes HJ, ed. Mycoplasmosis in Poultry. American Association of Avian Pathologists; 2003:1-38.

[10] Lauerman LH, Hoerr FJ, Sharpton AR, et al. Development and application of a multiplex PCR for detection of Mycoplasma gallisepticum, M. synoviae, and M. meleagridis. Avian Dis. 1993;37(3):775-782.

[11] Garcia M, Ikuta N, Taniwaki SA, et al. Nested PCR detection of Mycoplasma gallisepticum in chicken flocks with suspected chronic respiratory disease. J Vet Diagn Invest. 2004;16(6):573-576.

[12] Raviv Z, Callison SA, Ferguson-Noel N, et al. A real time PCR targeting the gapA gene for detection of Mycoplasma gallisepticum. Avian Dis. 2007;51(2):507-512.

[13] Soeripto S, Whithear KG, Fenton S, et al. Multilocus sequence typing of Mycoplasma gallisepticum reveals a limited number of circulating clones. Vet Microbiol. 2010;142(1-2):89-97.

[14] Armour NK, Ferguson-Noel N. Evaluation of pooled sampling for detection of Mycoplasma gallisepticum by real time PCR. Avian Dis. 2010;54(1):116-119.

[15] Mekuria TA, Zhang S, Eastwood G, et al. Loop mediated isothermal amplification for rapid detection of Mycoplasma gallisepticum in field samples. J Vet Diagn Invest. 2014;26(6):767-773.

[16] Ferguson-Noel NM. Mycoplasma control and prevention in poultry. In: Veterinary Clinics of North America: Food Animal Practice. 2017;33(1):117-133.

[17] Marois C, Dufour-Gesbert F, Kempf I. Detection of Mycoplasma synoviae and M. gallisepticum from dust samples collected in poultry houses. Avian Pathol. 2002;31(6):571-577.

[18] Vancova M, Buresova L, Jochim A, et al. Darkling beetles as mechanical vectors of avian mycoplasmas. Med Vet Entomol. 2005;19(3):298-302.

[19] Levison S, Kleven SH. A comparison of egg dipping and egg injection for the control of Mycoplasma gallisepticum in breeder flocks. Avian Dis. 1992;36(1):82-87.

[20] Whithear KG. Attenuated Mycoplasma gallisepticum vaccines: comparison of F strain, ts-11, and 6/85. Aust Vet J. 2000;78(12):834-839.

[21] Noormohammadi AH, Jones JF, Hart DG, et al. Evaluation of the safety and efficacy of the MS-H vaccine strain against Mycoplasma synoviae infection. Avian Pathol. 2002;31(6):607-614.

[22] Evans JD, Levisohn S, Kleven SH. Efficacy of inactivated Mycoplasma gallisepticum vaccines in commercial layers. Avian Dis. 1998;42(2):279-286.

[23] Grodio JL, Raviv Z, Ferguson-Noel NM, et al. Development of a DIVA ELISA for Mycoplasma gallisepticum using a recombinant antigen. J Vet Diagn Invest. 2009;21(5):678-683.

[24] Kempf I, Gesbert F, Froyman R, et al. Efficacy of tilmicosin against Mycoplasma gallisepticum infection in chickens. Avian Dis. 1995;39(2):369-375.

[25] Gerchman I, Lysnyansky I, Perk S, et al. Macrolide resistance in Mycoplasma gallisepticum field isolates from commercial poultry. Antimicrob Agents Chemother. 2008;52(4):1318-1322.

[26] Kleven SH. Eradication of Mycoplasma gallisepticum from primary breeder flocks: a 20 year experience. Avian Pathol. 2008;37(3):237-241.

[27] Crespo R, Jeffrey JS, Kinsella ME, et al. Mycoplasma gallisepticum in backyard chickens: prevalence, risk factors, and owner awareness. J Am Vet Med Assoc. 2016;249(1):85-92.

[28] Ley DH, Reynolds DL, Barnes HJ. Mycoplasma gallisepticum: ultrastructure and cytopathology. Avian Pathol. 1987;16(2):217-231.

[29] Tully JG, Razin S. Diagnostic methods for mycoplasmas. In: Maniloff J, ed. Mycoplasmas: Molecular Biology and Pathogenesis. ASM Press; 1992:153-173.

[30] Ball HJ, Mackie DP, Logan EF. Application of PCR for the detection of Mycoplasma bovis and M. gallisepticum. J Clin Microbiol. 1993;31(8):2000-2002.

[31] Nascimento ER, Yogev D, Razin S, et al. A PCR based assay for the detection of Mycoplasma gallisepticum in field samples. Avian Dis. 1991;35(4):775-781.

[32] Ikuta N, Taniwaki SA, Timenetsky J, et al. Evaluation of a multiplex PCR for detection of Mycoplasma synoviae and M. gallisepticum in Brazilian poultry flocks. Braz J Microbiol. 2005;36(4):369-373.

[33] Hess M, Neubauer C, Hackl R. Interlaboratory comparison of PCR methods for detection of Mycoplasma gallisepticum. Avian Dis. 2006;50(4):528-532.

[34] Ferguson-Noel NM, Cookson K, Laiblin VA, et al. The efficacy of a commercial ts-11 Mycoplasma gallisepticum vaccine in commercial layers. Avian Dis. 2002;46(3):586-593.

[35] Boonyawiwat V, Srikitjakarn L, Tirawatnapong N, et al. Seroepidemiology of Mycoplasma gallisepticum and M. synoviae in Thai commercial chickens. Thai J Vet Med. 2009;39(4):327-334.

[36] Lierz M, Segalés J, Hafez HM. Detection of Mycoplasma gallisepticum and Mycoplasma synoviae in wild birds. Vet Rec. 2008;163(7):210-213.

[37] Kleven SH, King DD, Anderson DP. Airsacculitis in broilers from Mycoplasma gallisepticum and E. coli coinfection. Avian Dis. 1978;22(4):682-692.

[38] Bradbury JM, Jordan FTW. The immunogenicity and pathogenicity of Mycoplasma gallisepticum after passage in eggs. Vet Rec. 1970;86(21):609-614.

[39] Stipkovits L, Kempf I. Mycoplasmoses in poultry. Rev Sci Tech. 1996;15(4):1495-1525.

[40] Marois C, Dufour-Gesbert F, Kempf I. Comparison of different DNA extraction methods for detection of Mycoplasma gallisepticum by PCR. J Vet Med B Infect Dis Vet Public Health. 2004;51(1):29-33.

[41] Rousset E, Montreuil S, Poitras E, et al. Detection of Mycoplasma gallisepticum in environmental samples from commercial poultry houses. Avian Dis. 2012;56(2):370-374.

[42] Ferguson-Noel NM, Williams SM, Brannan CH, et al. Field evaluation of a commercial Mycoplasma gallisepticum ELISA. Avian Dis. 2005;49(3):404-407.

[43] Sakoda Y, Shimazaki Y, Sato S, et al. Development of a loop mediated isothermal amplification assay for Mycoplasma synoviae. J Vet Diagn Invest. 2008;20(2):207-210.

[44] Raviv Z, Ferguson-Noel NM, Kleven SH. Comparison of diagnostic methods for detection of Mycoplasma gallisepticum in commercial chicken flocks. Avian Dis. 2005;49(1):77-82.

[45] Gagkaev A, Baranova OA, Vasiliev DA, et al. Antimicrobial sensitivity of Mycoplasma gallisepticum and M. synoviae isolates from Russian farms. Vet World. 2017;10(7):801-806.

[46] Landman WJ, van Eck JH. The incidence and economic significance of eggshell apex abnormalities in Dutch layer flocks. Tijdschr Diergeneeskd. 2012;137(10):674-679.

[47] Noormohammadi AH, Markham PF, Markham JF, et al. Temperature sensitive mutants of Mycoplasma synoviae as vaccine candidates. Vaccine. 2003;21(27-30):4121-4128.

[48] Gerchman I, Levisohn S, Mikula I, et al. Characterization of Mycoplasma gallisepticum field isolates from Europe and Israel. Avian Pathol. 2001;30(6):611-617.

[49] Sahu SP, Van Ess J, Olson LD. Role of the environment in transmission of Mycoplasma gallisepticum in turkeys. Avian Dis. 1994;38(3):505-511.

[50] Yadav G, Mohan M, Gupta RP, et al. Molecular detection and genetic diversity of Mycoplasma gallisepticum in Indian poultry. Indian J Anim Sci. 2019;89(3):283-287.